Table 1.
Demographics.
| Variable | Value |
|---|---|
| Age (year)a | 67 (37–82) |
| Genderb | |
| Male | 63 (75) |
| Female | 21 (25) |
| Pathological tumor stagingb | |
| T1 | 8 (9.5) |
| T2 | 33 (39.3) |
| T3 | 26 (31.0) |
| T4 | 17 (20.2) |
| No. of tumorsb | |
| 1 | 61 (72.6) |
| 2 or more | 23 (27.4) |
| Tumor gradeb | |
| Low–intermediate | 8 (9.5) |
| High | 76 (90.5) |
| Size (cm)b | |
| ≥3 | 59 (70.2) |
| <3 | 25 (29.8) |
| Hydronephrosisb | |
| Yes | 38 (45.2) |
| No | 46 (54.8) |
| Pathological LN involvementb | |
| Yes | 35 (41.7) |
| No | 49 (58.3) |
| Bloods takena | 5 (1–16) |
| Hemoglobin (g/dL) | |
| Male | 11.8 (8.1–15.4) |
| Female | 12.0 (8.3–14.0) |
| Platelet (×109/L)a | 282 (86–636) |
| Neutrophils (×109/L)a | 63.95 (44.3–87.3) |
| Lymphocytes (×109/L)a | 23.3 (6.7–42.5) |
| Neutrophil-lymphocyte ratioa | 2.69 (1.00–12.39) |
| NLR breakdownb | |
| ≥2.7 | 45 (53.6) |
| <2.7 | 39 (46.4) |
LN, lymph node; NLR, neutrophil-to-lymphocyte ratio.
a
Presented as median (range).
b
Presented as n (%).